| Literature DB >> 35663039 |
Bang-Zhi Li1,2, Wen-Hai Tang3, Yang Li1,2, Lei Zhou1,2, Ming-Guo Liu2,4,5, Sheng-Xue Bao6.
Abstract
Aims: To compare the effectiveness of cervical epidural injections of local anesthetic with vs. without a steroid.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35663039 PMCID: PMC9162875 DOI: 10.1155/2022/8952220
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Qualitative modified approach to grading of evidence.
| Level | Strength of evidence | Description |
|---|---|---|
| I | Strong | Evidence obtained from multiple relevant high-quality randomized controlled trials |
|
| ||
| II | Moderate | Evidence obtained from at least one relevant high-quality randomized controlled trial or multiple relevant moderate- or low-quality randomized controlled trials |
|
| ||
| III | Fair | Evidence obtained from at least one relevant moderate- or low-quality randomized controlled trial with multiple relevant observational studies |
|
| ||
| IV | Limited | Evidence obtained from multiple moderate- or low-quality relevant observational studies |
|
| ||
| V | Consensus-based | Opinion or consensus of a large group of clinicians and/or scientists |
Figure 1Flow diagram illustrating published literature evaluating epidural injection in neck pain.
Methodologic quality assessment according to Cochrane review criteria.
| Manchikanti 2012 | Manchikanti 2013 | Manchikanti 2014 | Manchikanti 2018 | |
|---|---|---|---|---|
| Adequate randomization | Y | Y | Y | Y |
| Concealed treatment allocation | Y | Y | Y | Y |
| Patient blinded | Y | Y | Y | Y |
| Care provider blinded | Y | Y | Y | Y |
| Outcome assessor blinded | N | N | N | N |
| Dropout rate described | Y | Y | Y | Y |
| All randomized participants analyzed in the group | Y | Y | Y | Y |
| Reports of the study free of suggestion of selective outcome reporting | Y | Y | Y | Y |
| Groups similar at baseline with respect to most important prognostic indicators | N | Y | N | N |
| Cointerventions avoided or similar | Y | Y | Y | Y |
| Compliance acceptable in all group | Y | Y | Y | Y |
| Time of outcome assessment in all groups similar | Y | Y | Y | Y |
| Other sources of potential bias unlikely | Y | Y | Y | Y |
| Score | 11/13 | 12/13 | 11/13 | 11/13 |
Y: yes; N: no; U: unclear.
Methodologic quality assessment using the Interventional Pain Management Techniques-Quality Appraisal of Reliability and Risk of Bias Assessment instrument.
| Manchikanti 2012 | Manchikanti 2013 | Manchikanti 2014 | Manchikanti 2018 | |
|---|---|---|---|---|
| I. Trial design and guidance reporting | ||||
| 1. Consort or spirit | 3 | 3 | 3 | 3 |
| II. Design factors | ||||
| 2. Type and design of trial | 2 | 2 | 2 | 2 |
| 3. Setting/physician | 2 | 2 | 2 | 2 |
| 4. Imaging | 3 | 3 | 3 | 3 |
| 5. Sample size | 2 | 3 | 3 | 2 |
| 6. Statistical methodology | 1 | 1 | 1 | 1 |
| III. Patient factors | ||||
| 7. Inclusiveness of population | 2 | 2 | 2 | 2 |
| 8. Duration of pain | 2 | 2 | 2 | 2 |
| 9. Previous treatments | 2 | 2 | 2 | 2 |
| 10. Duration of follow-up with appropriate interventions | 2 | 3 | 3 | 2 |
| IV. Outcomes | ||||
| 11. Outcome assessment criteria for significant improvement | 4 | 4 | 4 | 4 |
| 12. Analysis of all randomized participants in the groups | 2 | 2 | 2 | 2 |
| 13. Description of dropout rate | 2 | 2 | 2 | 2 |
| 14. Similarity of groups at baseline for important prognostic indicators | 1 | 0 | 1 | 1 |
| 15. Role of cointerventions | 1 | 1 | 1 | 1 |
| V. Randomization | ||||
| 16. Method of randomization | 2 | 2 | 2 | 2 |
| VI. Allocation concealment | ||||
| 17. Concealed treatment allocation | 2 | 2 | 2 | 2 |
| VII. Blinding | ||||
| 18. Patient blinding | 1 | 1 | 1 | 1 |
| 19. Care provider blinding | 1 | 1 | 1 | 1 |
| 20. Outcome assessor blinding | 0 | 0 | 0 | 0 |
| VIII. Conflicts of interest | ||||
| 21. Funding and sponsorship | 2 | 2 | 2 | 2 |
| 22. Conflicts of interest | 3 | 3 | 3 | 3 |
| Score | 42 | 43 | 44 | 42 |
Characteristics of included studies on cervical epidural injections in neck pain.
| Study/study type | Participants and interventions | Outcome measure | Follow-up period | Conclusions |
|---|---|---|---|---|
| Manchikanti et al. (36)/RCT |
| NDI, NRS, opioid intake, work status | 1 year | Cervical interlaminar epidural injections had an efficacy of 71.5% for pain reduction and improvement in functional status for neck pain. |
|
| ||||
| Manchikanti et al. (37)/RCT |
| NDI, NRS, opioid intake, work status | 2 years | Cervical interlaminar epidural injections for chronic neck pain was effective in 72% of patients in group I and 68% of patients in group 2. |
|
| ||||
| Manchikanti et al. (38)/RCT |
| NDI, NRS, opioid intake, work status | 2 years | Cervical epidural injections of local anesthetic with or without steroids were effective in 71% of patients. |
|
| ||||
| Manchikanti et al. (39)/RCT |
| NDI, NRS, work status | 2 years | Cervical interlaminar epidural injections for chronic neck pain alleviated pain relief and improved functional status by ≥50% in 69% of patients in group I and 71% of patients in group 2 at the 2-year follow-up. |
IPM-QRB: Interventional Pain Management Techniques-Quality Appraisal of Reliability and Risk of Bias Assessment; NDI: Neck Disability Index; NRS: numeric rating scale; RCT: randomized controlled trial.
Figure 2Change in functional level using Neck Disability Index (NDI).
Figure 3Change in pain score level using numeric rating scale (NRS).
Figure 4Change in pain score level using numeric rating scale (NRS).
Figure 5Change in functional level using Neck Disability Index (NDI).
Figure 6Change in pain score level using numeric rating scale (NRS).
Figure 7Change in functional level using Neck Disability Index (NDI).